SQ Innovation, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its drug-device combination ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
FDA has approved the new furosemide injection for treating edema in adults with chronic heart failure.Lasix ONYU was ...
Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results